UOKiK Clears Two Pharma Acquisitions

Acquisitions by pharmaceutical companies Adamed and Cephalon have both been approved by UOKiK, Poland's Competition Authority.

Adamed was cleared to acquire over 85% of Polfa Pabianice's share capital (and, with it, control) from Polski Holding Farmaceutyczny S.A., controlled by the State Treasury. Both Adamed and Polfa Pabianice manufacture and sell pharmaceuticals. The acquisition enables Adamed to strengthen its production and research capabilities and extend its product range to include over-the-counter (non-prescription) medicines.

US company Cephalon Inc. has been cleared to take over control of Swiss company Mepha. Until now Cephalon had a subsidiary in Poland responsible for marketing its products and Mepha had no depending unit in Poland.